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Members of the diverse double- -barrel lineage of viruses are identiﬁed by the
conserved structure of their major coat protein. New members of this lineage
have been discovered based on structural analysis and we are interested in
identifying relatives that utilize unusual versions of the double- -barrel fold.
One candidate for such studies is P23-77, an icosahedral dsDNA bacteriophage
that infects the extremophile Thermus thermophilus. P23-77 has two major coat
proteins, namely VP16 and VP17, of a size consistent with a single- -barrel core
fold. These previously unstudied proteins have now been successfully expressed
as recombinant proteins, puriﬁed and crystallized using hanging-drop and
sitting-drop vapour-diffusion methods. Crystals of coat proteins VP16 and VP17
have been obtained as well as of a putative complex. In addition, virus-derived
material has been crystallized. Diffraction data have been collected to beyond
3A ˚ resolution for ﬁve crystal types and structure determinations are in progress.
1. Introduction
Analysis of virus structures determined over the past 30 years has led
to the concept of ‘viral self’ elements that can be used to trace ancient
evolutionary relationships (Benson et al., 1999; Bamford et al., 2005).
‘Viral self’ elements, vertically inherited elements that are required
to assemble a virion, such as capsid proteins, are key to the survival
of the virus; thus, while viral DNA may change, the structure and
architecture of the virus and its capsid proteins are preserved. One
such lineage, identiﬁed by conserved protein structures, containing
adenovirus and the bacterial virus PRD1 traces its roots back to
the divergence of the domains of life (Krupovic & Bamford, 2008;
Bamford et al., 2005). Modern members of this lineage are identiﬁed
primarily by a capsid protein fold containing a double  -barrel. This
structural signature has been observed in viruses such as adenovirus,
PRD1, STIV, PBCV-1, PM2 and recently vaccinia virus (Abrescia et
al., 2004, 2008; Bahar et al., 2011; Khayat et al., 2005; Nandhagopal
et al., 2002; Rux et al., 2003; Liu et al., 2010; Reddy et al., 2010), that
infect hosts from different domains of life.
P23-77 is a bacteriophage which appears to possess structural
elements that bear a novel relationship to the adeno/PRD1 lineage.
It has a T = 28 icosahedral capsid,  800 A ˚ across, with an internal
lipid membrane enclosing a circular dsDNA genome (Yu et al., 2006;
Jaatinen et al., 2008; Jalasvuori et al., 2009). The genome is approxi-
mately 17 000 nucleotides in length and contains 37 putative ORFs,
ten of which code for structural proteins (Jaatinen et al., 2008;
Jalasvuori et al., 2009). P23-77 has two major coat proteins, VP16
(20 kDa) and VP17 (32 kDa); they form, in an approximate 1:1 ratio,
a viral capsid with an unusual base-and-tower architecture reminis-
cent of the capsomeric structure observed in some members of the
adeno/PRD1 lineage but sited at positions in the icosahedral virus
that are not allowed for the adeno/PRD1 trimeric capsomers. Thus,
while in the adeno/PRD1 lineage the pseudo-hexameric capsomers
are formed by trimers composed of subunits harbouring a double-
 -barrel fold, in P23-77 some capsomers lie on icosahedral twofold
axes. This organization has only recently been identiﬁed in
extremophile viruses and has not been characterized at the level of
protein structure (Jaatinen et al., 2008; Ja ¨a ¨linoja et al., 2008). In
addition, sequence analysis of the packaging ATPase of P23-77suggests a relationship to the adeno/PRD1 double- -barrel lineage.
P23-77 may belong to an unknown ancestral branch of the double- -
barrel lineage that utilizes single- -barrel core structures instead of
the duplicate version and has modern members among extremophile
viruses, including the archaeal virus SH1 (Jalasvuori et al., 2009,
2010). Here, we report the crystallization and preliminary diffraction
analysis of VP16 and VP17, with the aim of ultimately solving their
structures by X-ray crystallography, in order to shed light on the
origins of P23-77 and its relatives.
2. Materials and methods
2.1. Plasmid construction
Genes ORF16 and ORF17 were PCR-ampliﬁed from the P23-77
genome using primers with restriction sites for NdeI and HindIII
and corresponding to full-length VP16 (1–173) and VP17 (1–291),
respectively. Puriﬁed restricted PCR fragments were ligated with
NdeI–HindIII-restrictedexpressionvectorpET22b(+)(Novagen)and
the resulting recombinant plasmids pIR1 (ORF17/pET22b) and pIR2
(ORF16/pET22b) were used to transform competent Escherichia coli
HMS174 (DE3) for high-level recombinant protein expression using
standard methods.
2.2. Protein expression and purification
Large-scale cultures of E. coli HMS174 (DE3) transformed with
each plasmid were grown (12   400 ml LB medium with 150 mgm l
 1
ampicillin, 310 K, 230 rev min
 1) until the absorbance at 550 nm
reached 0.5, at which point recombinant protein expression was
induced by the addition of IPTG to a ﬁnal concentration of 1 mM.
Cultures were grown for 22 h. Cells were collected by centrifugation,
resuspended to one hundreth of the original volume in 20 mM Tris
pH 7.4, 50 mM NaCl buffer and disrupted with a French press
(Thermo Fisher Scientiﬁc). Soluble fractions containing target
proteins were seperated from cell debris by centrifugation (Beckman
Ti-70 rotor, 33 000 rev min
 1, 2 h, 278 K).
Supernatants containing VP16 or VP17 were incubated at 363 K
for 10 min, which caused degradation of the less heat-stable host-
derived proteins. Degraded material was removed by centrifugation,
after which samples were concentrated and buffer-exchanged (20 mM
ethanolamine pH 9, 50 mM NaCl for VP16 and 20 mM ethanolamine
pH 9.5 for VP17) using an Amicon ultraﬁltration system (Millipore).
VP16 was loaded onto an anion-exchange chromatography column
[5 mlQHP HiTrapcolumn(GEHealthcare)equilibratedwith20 mM
ethanolamine pH 9 at 295 K]. The ﬂowthrough containing VP16 was
further puriﬁed by size-exclusion chromatography [HiLoad 26/60
Superdex 200 prep-grade column (GE Healthcare) equilibrated with
20 mM Tris pH 7.4, 150 mM NaCl at 295 K]. VP17 was puriﬁed with a
similaranion-exchangechromatographyprotocolinwhichthecolumn
was equilibrated with 20 mM ethanolamine pH 9.5 and the protein
was eluted speciﬁcally with 50 mM NaCl. Fractions containing VP17
were puriﬁed by size-exclusion chromatography as for VP16. After
size-exclusion chromatography, fractions containing pure VP16 or
VP17 were pooled, concentrated, exchanged into 20 mM Tris pH 7.4
buffer and stored at 280 K. Puriﬁed VP16 and VP17 were concen-
trated using 10 kDa molecular-weight microconcentrators (Amicon).
2.3. P23-77 virus purification
Virus particles were produced in T. thermophilus strain
ATCC33923 and puriﬁed as described previously (Jaatinen et al.,
2008). In brief, cells were infected at a cell density of 7   10
8 cfu ml
 1
with a multiplicity of infection (MOI) of around 10. Viral particles
were precipitated from the lysate with 12% polyethylene glycol
(PEG) 6000 and 0.5 M NaCl and concentrated to one twentieth of the
original lysate volume in TV buffer (20 mM Tris–HCl pH 7.5, 5 mM
MgCl2, 150 mM NaCl). Viruses were puriﬁed by rate zonal centri-
fugation [linear 5–20%(w/v) sucrose gradient in TV buffer,
23 000 rev min
 1, 45 min, 298 K], followed by equilibrium centrifu-
gation in 1.30 mg ml
 1 CsCl2 in TV buffer (21 000 rev min
 1,1 6h ,
298 K). 2  puriﬁed viral particles were collected by differential
centrifugation (32 000 rev min
 1, 4 h, 298 K) and the virus pellet was
suspended in TV buffer. Puriﬁed virus samples were stored at 295 K.
3. Results
3.1. Crystallization
Crystallization conditions for puriﬁed full-length VP16 (1–173) and
full-length VP17 (1–291) and the P23-77 virion were initially screened
by hanging-drop vapour diffusion using a Mosquito Nanodrop
Crystallization Robot (TTP LabTech) at the University of Jyva ¨skyla ¨,
Finland. Subsequently, ﬁnal crystallization experiments were
performed at the Division of Structural Biology, Oxford University,
England either by setting up crystallization experiments manually or
by using the nanolitre high-throughput facility with sitting-drop sizes
of 1 ml+1ml and 100 nl + 100 nl (protein solution and crystallization
screen), respectively (Walter et al., 2005). Commercially available
crystallization screening kits (Hampton Research, California, USA,
Molecular Dimensions, UK and Emerald BioStructures, Washington,
USA) were used for all initial experiments. 576 crystallization
conditions were tested for VP16 and 288 conditions were tested for
VP17, whilst the VP16–VP17 complex was screened against 984
conditions. Virion crystallization was tested against 480 conditions.
All crystallizations were set up at room temperature (293–295 K). A
number of different crystal forms were obtained.
VP16 type 1 crystals grew within 1–2 weeks from microlitre drops
of protein (2–3 mg ml
 1) mixed in a 1:1(v:v) ratio with a solution
consisting of 5%(w/v) PEG 1000 and 5%(w/v) PEG 8000 dissolved
in autoclaved water (the crystallization drop was pH 7.4). Additional
screening experiments carried out in 96-well plates in the high-
throughput crystallization facility (Walter et al., 2005) yielded VP16
type 2 crystals. These crystals grew within days from 20%(w/v)
polyethylene glycol 6000, 0.1 M citrate pH 4.
VP17 crystals were obtained from drops consisting of 1 ml protein
solution (2–3 mg ml
 1) mixed with 1 ml1 . 9M sodium formate, 0.1 M
bis-Tris buffer pH 7.0. Crystals grew to full size in two weeks.
In an attempt to obtain the structure of a VP16–VP17 complex,
VP16 and VP17 were mixed at concentrations of 1.7 and 2.0 mg ml
 1,
respectively (i.e. a 1:1 molar ratio); one well diffracting crystal, which
was used for data collection, took three months to grow from 1.1 M
diammonium tartrate pH 7.
Crystals were also obtained from experiments using the whole
P23-77 virion. Crystallization conditions were screened in 96-well
plates with virion concentrations ranging from 1.0 to 2.5 mg ml
 1.
Thin needles appeared in various conditions, all of which contained
0.1 M citric acid pH 3.5 and PEG. Crystals appeared within 12 h to 8 d
depending on the buffer conditions, virion concentration and virus
preparation. Crystals used for diffraction analysis were grown in
microlitre drops which were set up manually at a virus concentration
of 2.4 mg ml
 1 and a virus:reservoir ratio of 1:1(v:v). The reservoir
solution consisted of 0.1 M citric acid pH 3.5, 20 mM Tris–HCl pH 7.5,
5m M MgCl2, 150 mM NaCl and 25% PEG 3350. All ﬁve crystal types
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derived material are illustrated in Fig. 1.
3.2. X-ray characterization and data collection
All crystals were cooled in liquid nitrogen using glycerol mixed
with reservoir solution at 25%(v/v) as a cryoprotectant and exposed
to X-rays at 100 K. Initially, crystals of VP16 type 1 and VP17 were
characterized at Jyva ¨skyla ¨ and Oxford using in-house X-ray equip-
ment. Subsequently, deﬁnitive data sets for all crystals were collected
at the Diamond Light Source synchrotron, Didcot, England as
follows. VP16 type 1 data were collected on beamline I03
(  = 0.979 A ˚ ) in high- and low-resolution sweeps, with the high-
resolution sweep consisting of 360 images with 0.5  oscillation per
image and an exposure time of 1 s per image. VP16 type 2 data were
collected on beamline I04 (  = 1.000 A ˚ ) as 360 images with 1  and 1 s
crystallization communications
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Figure 1
Crystals of the major coat proteins of P23-77: (a) VP16 type 1, (b) VP16 type 2, (c) VP17, (d) putative complex, (e) virus-derived crystals. (b), (d) and (e) show crystals frozen
in loops that were used for data collection at the beamline.
Table 1
Data-collection and processing statistics.
Values in parentheses are for the highest resolution shell. Each data set was collected from one crystal, except for the virus-derived crystal data set, which was collected from two.
VP16 type 1 VP16 type 2 VP17 Putative complex Virus-derived crystals
Space group P6222 C2 P6122 C2 P212121
Unit-cell parameters
a (A ˚ ) 61.9 76.6 107.2 76.8 41.8
b (A ˚ ) 61.9 68.6 107.2 69.6 78.2
c (A ˚ ) 251.2 31.6 233.8 81.6 405.8
  ( ) 9 09 09 09 09 0
  ( ) 90 96.4 90 105.0 90
  ( ) 120 90 120 90 90
Resolution (A ˚ ) 62.8–1.80 (1.85–1.80) 34.3–1.26 (1.30–1.26) 59.7–2.26 (2.32–2.26) 39.6–1.53 (1.57–1.53) 51.2–2.92 (2.99–2.92)
Rmerge† 0.075 (1.045) 0.053 (0.626) 0.082 (0.917) 0.064 (1.015) 0.301 (1.492)
hI/ (I)i 30.7 (3.3) 23.1 (2.6) 38.6 (5.3) 17.7 (2.9) 6.4 (1.5)
Completeness (%) 100 (100) 85.8 (41.4) 100 (100) 98.4 (83.3) 99.9 (99.8)
Multiplicity 28.5 (21.0) 7.5 (6.5) 35.5 (36.6) 6.3 (4.4) 6.3 (5.6)
† Rmerge =
P
hkl
P
i jIiðhklÞ h IðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the ith measurement and hI(hkl)i is the weighted mean of all measurements Ii(hkl).per image. VP17 data were collected on beamline I04 (  = 1.000 A ˚ )a s
614 images with 0.5  and 1 s per image. The data for the putative
complex were collected on beamline I24 (  = 1.071 A ˚ ) as 1800 images
with 0.2  and 0.2 s per image. Data for the virion-derived crystal were
collected on beamline I24 (  = 0.969 A ˚ )a s2  450 images with 0.2 
and 0.2 s per image. All crystals diffracted to better than 3 A ˚ reso-
lution. Data were automatically processed with xia2/XDS (Winter,
2010; Kabsch, 1993) and the processing statistics are summarized in
Table 1.
4. Discussion
P23-77 major capsid proteins VP16 and VP17 have been puriﬁed,
crystallized and native data sets collected. The host of bacterio-
phage P23-77 is the extremophile T. thermophilus and consequently
the thermal stability of the P23-77 proteins made puriﬁcation
straightforward; raising the temperature of the clariﬁed supernatant
to 363 K for 10 min degraded and precipitated most cellular proteins.
Preliminary data analyses indicate that the asymmetric units of
VP16 type 1 and VP16 type 2 are likely to contain one subunit of
VP16 each (corresponding to solvent contents of 65 and 41%,
respectively); the asymmetric unit of VP17 probably contains two
subunits of VP17 (corresponding to a solvent content of 59%) and
the asymmetric unit of the putative complex could accommodate one
subunit each of VP16 and VP17 (corresponding to a solvent content
of 40%). The unit cell of the crystal derived from virus crystallization
is far too small to contain the whole virus (which is some 800 A ˚
across, exceeding a complete unit cell in every direction). It is very
likely to contain VP16 and/or VP17 (for example, six subunits of
VP16 in the crystallographic asymmetric unit would correspond to
a solvent content of 55%, whereas four subunits of VP17 would
correspond to 52% solvent). Asearch for heavy-atom derivatives is in
progress. Structures of major capsid proteins VP16 and VP17, which
are the building blocks of P23-77, and their complexes will provide
details of both their oligomeric states and how they assemble to form
part of the capsid of P23-77. This will contribute to the overall picture
of the evolutionary relationships in this diverse group of dsDNA
viruses.
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